Independence of HIF1a and androgen signaling pathways in prostate cancer
<br><strong>Background: </strong>Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progression to castrate-resistant prostate canc...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature
2020
|
| _version_ | 1826297840303865856 |
|---|---|
| author | Tran, MGB Bibby, BAS Yang, L Lo, F Warren, AY Shukla, D Osborne, M Hadfield, J Carroll, T Stark, R Scott, H Ramos-Montoya, A Massie, C Maxwell, P West, CML Mills, IG Neal, DE |
| author_facet | Tran, MGB Bibby, BAS Yang, L Lo, F Warren, AY Shukla, D Osborne, M Hadfield, J Carroll, T Stark, R Scott, H Ramos-Montoya, A Massie, C Maxwell, P West, CML Mills, IG Neal, DE |
| author_sort | Tran, MGB |
| collection | OXFORD |
| description | <br><strong>Background: </strong>Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progression to castrate-resistant prostate cancer (CRPC). Hypoxia and HIF1a have been implicated in the development of resistance to androgen targeted therapies and progression to CRCP. The interplay between the androgen and hypoxia/HIF1a signaling axes was investigated.</br>
<br><strong>Methods: </strong>In vitro stable expression of HIF1a was established in the LNCaP cell line by physiological induction or retroviral transduction. Tumor xenografts with stable expression of HIF1a were established in castrated and non-castrated mouse models. Gene expression analysis identified transcriptional changes in response to androgen treatment, hypoxia and HIF1a. The binding sites of the AR and HIF transcription factors were identified using ChIP-seq.</br>
<br><strong>Results: </strong>Androgen and HIF1a signaling promoted proliferation in vitro and enhanced tumor growth in vivo. The stable expression of HIF1a in vivo restored tumor growth in the absence of endogenous androgens. Hypoxia reduced AR binding sites whereas HIF binding sites were increased with androgen treatment under hypoxia. Gene expression analysis identified seven genes that were upregulated both by AR and HIF1a, of which six were prognostic.</br>
<br><strong>Conclusions: </strong>The oncogenic AR, hypoxia and HIF1a pathways support prostate cancer development through independent signaling pathways and transcriptomic profiles. AR and hypoxia/HIF1a signaling pathways independently promote prostate cancer progression and therapeutic targeting of both pathways simultaneously is warranted.</br>
|
| first_indexed | 2024-03-07T04:37:46Z |
| format | Journal article |
| id | oxford-uuid:d08d138f-9d31-4c49-9384-a618760c0d29 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:37:46Z |
| publishDate | 2020 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:d08d138f-9d31-4c49-9384-a618760c0d292022-03-27T07:50:47ZIndependence of HIF1a and androgen signaling pathways in prostate cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d08d138f-9d31-4c49-9384-a618760c0d29EnglishSymplectic ElementsSpringer Nature2020Tran, MGBBibby, BASYang, LLo, FWarren, AYShukla, DOsborne, MHadfield, JCarroll, TStark, RScott, HRamos-Montoya, AMassie, CMaxwell, PWest, CMLMills, IGNeal, DE<br><strong>Background: </strong>Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progression to castrate-resistant prostate cancer (CRPC). Hypoxia and HIF1a have been implicated in the development of resistance to androgen targeted therapies and progression to CRCP. The interplay between the androgen and hypoxia/HIF1a signaling axes was investigated.</br> <br><strong>Methods: </strong>In vitro stable expression of HIF1a was established in the LNCaP cell line by physiological induction or retroviral transduction. Tumor xenografts with stable expression of HIF1a were established in castrated and non-castrated mouse models. Gene expression analysis identified transcriptional changes in response to androgen treatment, hypoxia and HIF1a. The binding sites of the AR and HIF transcription factors were identified using ChIP-seq.</br> <br><strong>Results: </strong>Androgen and HIF1a signaling promoted proliferation in vitro and enhanced tumor growth in vivo. The stable expression of HIF1a in vivo restored tumor growth in the absence of endogenous androgens. Hypoxia reduced AR binding sites whereas HIF binding sites were increased with androgen treatment under hypoxia. Gene expression analysis identified seven genes that were upregulated both by AR and HIF1a, of which six were prognostic.</br> <br><strong>Conclusions: </strong>The oncogenic AR, hypoxia and HIF1a pathways support prostate cancer development through independent signaling pathways and transcriptomic profiles. AR and hypoxia/HIF1a signaling pathways independently promote prostate cancer progression and therapeutic targeting of both pathways simultaneously is warranted.</br> |
| spellingShingle | Tran, MGB Bibby, BAS Yang, L Lo, F Warren, AY Shukla, D Osborne, M Hadfield, J Carroll, T Stark, R Scott, H Ramos-Montoya, A Massie, C Maxwell, P West, CML Mills, IG Neal, DE Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title | Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title_full | Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title_fullStr | Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title_full_unstemmed | Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title_short | Independence of HIF1a and androgen signaling pathways in prostate cancer |
| title_sort | independence of hif1a and androgen signaling pathways in prostate cancer |
| work_keys_str_mv | AT tranmgb independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT bibbybas independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT yangl independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT lof independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT warrenay independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT shuklad independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT osbornem independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT hadfieldj independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT carrollt independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT starkr independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT scotth independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT ramosmontoyaa independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT massiec independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT maxwellp independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT westcml independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT millsig independenceofhif1aandandrogensignalingpathwaysinprostatecancer AT nealde independenceofhif1aandandrogensignalingpathwaysinprostatecancer |